IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

Influenza A virus (IAV)‐induced severe disease is characterized by infected lung epithelia, robust inflammatory responses and acute lung injury. Since type I interferon (IFNαβ) and type III interferon (IFNλ) are potent antiviral cytokines with immunomodulatory potential, we assessed their efficacy a...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:EMBO Mol Med
Hlavní autoři: Davidson, Sophia, McCabe, Teresa M, Crotta, Stefania, Gad, Hans Henrik, Hessel, Edith M, Beinke, Soren, Hartmann, Rune, Wack, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: John Wiley and Sons Inc. 2016
Témata:
Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5009813/
https://ncbi.nlm.nih.gov/pubmed/27520969
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201606413
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky